NNNN
Anbio Biotechnology Class A Ordinary SharesNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$276.51M
P/E Ratio
42.00
EPS
$0.15
Beta
—
52W High
$51.33
52W Low
$5.13
50-Day MA
$8.20
200-Day MA
$21.03
Dividend Yield
—
Profit Margin
74.10%
Forward P/E
—
PEG Ratio
—
About Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. The company is headquartered in Frankfurt am Main, Germany.
Fundamentals
| Revenue (TTM) | $8.65M |
| Gross Profit (TTM) | $7.54M |
| EBITDA | — |
| Operating Margin | 59.10% |
| Return on Equity | 27.10% |
| Return on Assets | 14.70% |
| Revenue/Share (TTM) | $0.20 |
| Book Value | $0.69 |
| Price-to-Book | 8.89 |
| Price-to-Sales (TTM) | 31.98 |
| EV/Revenue | 29.64 |
| EV/EBITDA | 44.43 |
| Quarterly Earnings Growth (YoY) | 2.80% |
| Quarterly Revenue Growth (YoY) | 73.90% |
| Shares Outstanding | $43.89M |
| Float | $39.69M |
| % Insiders | 4.79% |
| % Institutions | 4.95% |
Historical Volatility
HV 10-Day
92.42%
HV 20-Day
69.20%
HV 30-Day
90.24%
HV 60-Day
90.89%
HV Rank
—
Volatility is currently expanding
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NNNN and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/26/2026